We had the opportunity to sit down with Farzad Abdi-Dezfuli from Sarsia during #NLSdays, discussing their investment focus in two key areas: Life Sciences and Technology, Energy, and Sustainability. In Life Sciences, Sarsia is driving innovation by addressing unmet medical needs, turning cutting-edge lab results into life-saving treatments. In Technology, Energy, and Sustainability, they're investing in solutions that accelerate the green transition and build sustainable companies for a better future. Watch the full interview to learn more about their vision and impact!
BioStock - Connecting Innovation and Capital’s Post
More Relevant Posts
-
💡𝟰𝟱𝟬 𝗠𝗶𝗻𝗱𝘀, 𝟰𝟰 𝗕𝗼𝗼𝘁𝗵𝘀, 𝟭 𝗕𝗶𝗴 𝗗𝗼𝘀𝗲 𝗼𝗳 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗕𝘂𝘇𝘇🚀 For Evidentic, the third Antibody Industrial Symposium (AIS) in France was a dynamic event. It was the first time for Sofia and Andrea, who experienced the professional environment and valuable insights that AIS offers. With 450 participants and 44 booths, we engaged in numerous insightful talks and built strong connections. 🌟 𝗠𝗮𝗿𝗸𝗲𝘁 𝗧𝗿𝗲𝗻𝗱𝘀 & 𝗢𝗽𝘁𝗶𝗺𝗶𝘀𝗺 📈 The market is stable but optimistic for growth by the end of 2024. 🌍 The US remains crucial, but Europe, particularly Belgium and the Netherlands, is also key. 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆-𝗗𝗿𝘂𝗴 𝗖𝗼𝗻𝗷𝘂𝗴𝗮𝘁𝗲𝘀 (𝗔𝗗𝗖𝘀) 📊 Significant focus on ADCs, evident from the many posters dedicated to this area. 🧬 Emphasis on developing both first-in-class and best-in-class therapies, showcasing strong innovation. 𝗧𝗲𝗮𝗺𝘄𝗼𝗿𝗸 & 𝗖𝘂𝘀𝘁𝗼𝗺𝗲𝗿 𝗖𝗼𝗻𝗻𝗲𝗰𝘁𝗶𝗼𝗻𝘀 🤝 The conference fostered closer team bonds and valuable interactions with potential customers. 💬 The well-organized event and specific questions from participants highlight growing interest in our products and services. The relaxed and approachable atmosphere, coupled with excellent organization, facilitated these interactions.🌐 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 & 𝗟𝗼𝗼𝗸𝗶𝗻𝗴 𝗔𝗵𝗲𝗮𝗱 Overall, the conference highlighted the importance of strong relationships and industry connections. The market remains optimistic for growth by the end of the year. We're excited to use the knowledge gained and continue positive interactions. 🚀📈 P.S. We're keeping an eye on the upcoming US election and its potential impact on the market. 👀 #AISCongress #Conference #IndustryInsights #Teamwork #CustomerConnection #Innovation #Research #Biotech #ADCs #Evidentic #MarketTrends #TeamBuilding #CustomerRelations #DrugDevelopment | MabDesign
-
🌟 **Day 1 for Innova Solutions at the DIA Global Annual Event in San Diego!** 🌟 What an incredible start to the DIA Global Annual Event here in sunny San Diego! The energy and enthusiasm were palpable as we kicked off with insightful keynotes, engaging panel discussions, and dynamic networking opportunities. **Highlights from Day 1:** 🔹 **Opening Keynote:** Visionary insights on the future of healthcare and innovation. A powerful message about the importance of collaboration in driving progress. 🔹 **Panel Discussions:** Thought-provoking sessions on topics such as digital transformation in clinical trials, regulatory challenges, and patient-centric drug development. The experts brought diverse perspectives that sparked meaningful conversations. 🔹 **Innovation Hub:** The exhibit hall was buzzing with cutting-edge solutions and technologies. It was great to see the latest advancements in pharma and biotech up close and personal. Gen AI/ML has been the key topics in the technology space of participating organizations. 🔹 **Networking:** Connecting with industry leaders, peers, and new contacts was a highlight. The networking opportunities have been invaluable for exchanging ideas and forging new partnerships. Looking forward to the next few days of learning, sharing, and growing together. Stay tuned for more updates! DIA #DIA2024 #HealthcareInnovation #Pharma #Biotech #SanDiego #InnovaSolutions #LifeScineces
-
We are proud to announce that Alcedis is the newest member of the bioRN Life Science Cluster. As one of Germany's strongest #biotech and life-science hubs, #bioRN plays a pivotal role in driving health innovations by facilitating valuable connections between regional and international stakeholders in the biotech sector. Becoming part of this network presents exciting opportunities for our work, enabling us to access new markets, foster collaboration, and develop innovative solutions to advance clinical research. Hanno Härtlein Dr. Benedikt Linder #LifeScience #ClinicalTrials
-
-
𝐄𝐮𝐫𝐨𝐩𝐞 𝐜𝐚𝐧 𝐲𝐨𝐮 𝐡𝐞𝐚𝐫 𝐮𝐬? 📞 𝐆𝐥𝐚𝐝 𝐲𝐨𝐮 𝐝𝐢𝐝, 𝐛𝐮𝐭 𝐢𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐪𝐮𝐢𝐭𝐞 𝐚 𝐫𝐢𝐝𝐞 𝐦𝐲 𝐝𝐞𝐚𝐫! 🎢 ⭐ Today, it’s personally rewarding to see this ambitious yet very comprehensive project, aimed at driving the adoption of new cancer treatments, coming to life with the endorsement of the European Commission. 🌱 The potential of astatine-211 as a promising alpha therapy required this EUR 16 million investment and structured collaboration over the next five years to unlock its full potential. 🏥 IBA is getting closer to patients, facilitating trials and research to address unmet clinical needs in pancreatic cancer, triple-negative breast cancer, and glioblastoma. These efforts will generate the clinical evidence astatine-211 is missing. 🫵 I’m grateful for the many people I’ve met along the way who turned this sound project into a reality. 🌞 𝐂𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐯𝐞 𝐞𝐟𝐟𝐨𝐫𝐭 𝐚𝐭 𝐢𝐭𝐬 𝐟𝐢𝐧𝐞𝐬𝐭! Partners: Institut Jules Bordet, Institut de Cancérologie de l'Ouest (ICO), Erasmus MC, Arronax Nantes, Forschungszentrum Jülich, National Centre for Nuclear Research , Rigshospitalet, Københavns Universitet - University of Copenhagen, INSERM, SCK CEN, Universidade de Coimbra, TetraKit Technologies, Oncidium foundation, LabLogic Systems, Vicomtech, Université libre de Bruxelles With the support from: Innovative Health Initiative (IHI), COCIR, EFPIA - European Federation of Pharmaceutical Industries and Associations, EuropaBio - the European Association for Bioindustries, MedTech Europe, Vaccines Europe
Breaking News 📢 We are proud to announce that IBA and Jules Bordet Institute will lead IHI project AccelerateEU to create complete Astatine-211 value chain. As the industry leader of the AccelerateEU initiative, IBA will facilitate the development of a production network to enable greater access to targeted alpha therapy across the EU through the development of a new alpha-machine cyclotron as an in-kind contribution. IBA will also work in close collaboration with the Jules Bordet Institute, the academic and clinical AccelerateEU coordinator, to manage the project. Curious to learn more about this project? Read our Press Release 👉 https://bit.ly/3Bxkeg3 Don't miss the next updates about this fascinating project and follow Accelerate.EU account. #IBA #Astatine #AccelerateEU #IHI Innovative Health Initiative (IHI)
-
Have you registered 𝗳𝗼𝗿 #𝗛𝗼𝗿𝗶𝘇𝗼𝗻𝟮𝟬𝟮𝟰 yet? If not here's a special network discount to make sure you will not miss the Horizon 2024 conference for 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻𝘀, 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗠𝗮𝗿𝗸𝗲𝘁 𝗔𝗰𝗰𝗲𝘀𝘀 𝗳𝗼𝗿 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗮𝗻𝗱 𝗜𝗩𝗗𝘀! Read more and register: https://horizon-2024.com/ 🌍 #Copenhagen, #Denmark 📅 20-21 November 2024 👉Evnia is a silver sponsor and its team will be on-site to welcome and meet you in person! Efstathios Vassiliadis Susanne Holm Faarbæk Vicky Valla, Ph.D. Gitte Juel Holst Katerina Slouka Bioevents - Sharing Biomed Knowledge 👉The conference, chaired by RQM+'s Amie Smirthwaite, PhD, FRAPS will examine the interplay between regulatory science, demonstration of device safety and performance, and development of an effective pre-and #postmarket #clinicalevidence strategy. It will also address critical operational issues including #datamanagement, #statistics, cost-effective study design, outsourcing, #reimbursement planning, and more! Some of the top clinical, regulatory, and industry experts in #Europe are attending! #medtechnews #biotechnews #medtech #biotech #invitrodiagnostics #notifiedbodies #postmarketsurveillance #clinicalinvestigations #dispositivosmedicos #dispositifsmedicaux #dispositivimedici #medizinprodukte #realworlddata #realworldevidence #cemark #cemarking #EVNIA_AR #Evnia_UKPR #PMCF #regulatoryaffairs #dansk
-
-
🧬ATMPs are highly innovative technologies developed as a result of a long, complex and often difficult research, development and market access process. 👩🔬As these transformative therapies come to the European market in greater numbers, and as their importance to the competitiveness of the Single Market is becoming increasingly apparent, we put together a short but comprehensive guide to the ATMP lifecycle, zeroing in on the complex processes and most significant hurdles developers must navigate at each stage of the cycle. 🔬Click here to find out what it takes to bring ATMPs to the lives of European patients: https://lnkd.in/eKhrXqwF #ATMPs #cellandgenetherapy #orphandrug #innovation
-
-
At #ISPOREurope 2024 in Barcelona Roche France and Horiana exhibited posters on 2 hot topics: 👉 One showing that aggregated data for Matching Adjusted Indirect Comparison can provide robust evidence using Quantitative Bias analysis. This is the first time that QBA is used in MAIC. 👉 The other one describing the first results of the real world study evaluating the new #MSAS questionnaire regarding autonomy of patient suffering of multiple sclerosis.
-
-
Looking back on an inspiring week at MEDICA - Leading International Trade Fair in Düsseldorf 🚀 Our #EUeic companies unveiled the future of #healthcare at the EIC Pavilion. Key takeaways from the week: 👉 Valuable peer-to-peer exchanges between companies 👉 Insightful panel discussions on the EIC role in supporting #deeptech companies 👉 Reverse pitch sessions with top industry leaders 👉 Visits from the American Chamber of Commerce to the European Union (AmCham EU) and EIT Health Don’t miss the highlights with our recap video 🎥 #EICatMEDICA2024 #eicBAS AkknaTek GmbH Axelera AI BrainCapture Check Point Care Dermagnostix GlucoSet GO-Pen ApS Interlinked AB METAFORA biosystems MYSPHERA PhosPrint P.C. Plas-Free POROUS Sequentia Biotech Time is Brain Hotzymes Modulux3D PhysioMRI Gisela Santos ANDREAS LYMBERIS Nassima Ferahtia Stéphane Ouaki 🇺🇦🇪🇺
-
𝐕𝐢𝐜𝐭𝐨𝐫𝐢𝐚 𝐢𝐬 𝐟𝐨𝐫𝐠𝐢𝐧𝐠 𝐝𝐞𝐞𝐩𝐞𝐫 𝐭𝐢𝐞𝐬 𝐰𝐢𝐭𝐡 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚 𝐢𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬, 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐢𝐦𝐩𝐚𝐜𝐭𝐟𝐮𝐥 𝐢𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐚𝐝𝐯𝐚𝐧𝐜𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧. Explore the latest industry insights, including the Korea Health Industry Development Institute (KHIDI) and mRNA Victoria's commitment to jointly explore mRNA-based research, development, investment, clinical trials and commercialisation opportunities. Learn more here: https://lnkd.in/g5uGkaGa Carolina Modesto | Yoshiko Tanaka #KoreaVictoriaPartnership #LifeSciences
-
